Tekla Life Sciences Investors carries a market capitalization of 603.82M, placing it among publicly traded companies globally.
| Market Cap | 603.82M |
| Enterprise Value | N/A |
Tekla Life Sciences Investors's stock has gained approximately 50.32097% over the past 52 weeks. The 50-day moving average sits at 18.68, while the 200-day moving average is 17.44.
| Beta (5Y) | N/A |
| 52-Week Price Change | 50.32097% |
| 50-Day Moving Average | 18.68 |
| 200-Day Moving Average | 17.44 |
| Average Volume (20 Days) | N/A |